首页 › 头颈鳞状细胞癌 › 俄亥俄州 › Cincinnati
Cincinnati OH 头颈鳞状细胞癌临床试验
14项针对 头颈鳞状细胞癌的研究正在 Cincinnati及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
招募中2/3 期
- Site#0117, Cincinnati
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
招募中3 期
- University of Cincinnati, Cincinnati
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
招募中3 期
- University of Cincinnati, Cincinnati
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
招募中2 期
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 距离 15 英里
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
招募中2 期
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- 以及另外 4 项
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
招募中观察性研究
- University of Cincinnati, Cincinnati
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
招募中2 期
- St. Elizabeth Healthcare, Edgewood · 距离 8 英里
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
招募中2 期
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 距离 15 英里
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
招募中3 期
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 距离 15 英里
Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
招募中1/2 期
- University of Cincinnati Medical Center, Cincinnati
Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma
招募中2 期
- University of Cincinnati Medical Center, Cincinnati
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 113, Cincinnati
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
招募中1/2 期
- The Christ Hospital, Cincinnati
其他城市的 头颈鳞状细胞癌试验
- Houston, TX47 项研究
- Los Angeles, CA42 项研究
- Boston, MA40 项研究
- Nashville, TN39 项研究
- New York City, NY39 项研究
- St. Louis, MO28 项研究
- Arlington, VA26 项研究
- Chicago, IL26 项研究
- Philadelphia, PA26 项研究
- Atlanta, GA24 项研究
- Pittsburgh, PA22 项研究
- New Haven, CT22 项研究
Cincinnati的其他研究
- 非小细胞肺癌35 项研究
- 癌症（所有类型）27 项研究
- 乳腺癌25 项研究
- 心力衰竭24 项研究
- 结直肠癌21 项研究
- 急性髓系白血病20 项研究
- 转移性癌症20 项研究
- 卵巢癌19 项研究
- 肺癌19 项研究
- 肥胖症19 项研究
- 前列腺癌18 项研究
- 多发性骨髓瘤17 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。